Comparision of FIBTEM and Blood-loss
Launched by JOHANN WOLFGANG GOETHE UNIVERSITY HOSPITAL · Jun 3, 2013
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • full sternotomy age \>18 Inform consent signed
- Exclusion Criteria:
- • Hypofibrinogen
About Johann Wolfgang Goethe University Hospital
Johann Wolfgang Goethe University Hospital, located in Frankfurt am Main, Germany, is a prominent academic medical center affiliated with Goethe University. Renowned for its commitment to advancing healthcare through innovative research and clinical excellence, the hospital serves as a vital hub for clinical trials and medical studies. It integrates cutting-edge technology with a multidisciplinary approach, facilitating collaboration among healthcare professionals to enhance patient outcomes. The hospital is dedicated to ethical research practices and adheres to stringent regulatory standards, ensuring the safety and well-being of trial participants while contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Frankfurt, Hessen, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials